References
- Dalakas MC. Polymyositis, dermatomyosilis and inclusion-body myositis. N Engl J Med. 1991; 325: 1487–98.
- Sigurgcirsson B, Lindclof B, Edhag O, AllanderE. Risk of cancer in patients with dermatomyosilis or polymyositis. N Engl J Med. 1992; 326: 363–7.
- Bonnetblanc JM, Bernard P, Fayol J. Dermatomyosilis and malignancy. Dermatologica. 1990; 180: 212–6.
- Cox NH, Lawrencew CM, Langtry JAA, Ivc FA. Disease associations and an evaluation of screening investigations for malignancy. Arch Dermatol. 1990; 126: 61–5
- Richardson JB, Callen JP. Dermatomyosilis and malignancy. Med Clin N Am. 1989; 73: 1211–20.
- Bohan A, Peter JB. Polymyositis and dermatomyosilis. N Engl J Med. 1975; 292: 344–7.
- Bohan A, Peter JB, Bowmanw RL, Pearson CM. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine. 1977; 56: 255–86.
- Kagen LJ, Aram S. Creatine kinase activity inhibitor in sera from patients with muscle disease. Arthritis Rheum. 1987; 30: 213–7.
- Callen JP. Myositis and malignancy. Curr Opin Rheumatol. 1994; 6: 590–4.
- Zantos D, Zhang Y, Felson D. The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol. 1994; 211: 1855–59.
- Barnes BE. Dermatomyositis and malignancy: a review of the literature. Ann Intern Med. 1976; 84: 68–76.
- Abeloff MD. Paraneoplastic syndromes, a window on the biology of cancer. N Engl J Med. 1987; 25:1588–600.